Search research articles
Contact Us
Filters
Showing results (121-130 of 174) with videos related to
Page
of 18
Sort By:
Haematologica
|
August 10, 2012
Safety of thalidomide in newly diagnosed elderly myeloma patients: a meta-analysis of data from individual patients in six randomized trials
Antonio Palumbo, Anders Waage, Cyrille Hulin, et al.
Critical Reviews in Oncology/Hematology
|
November 19, 2018
Continuous therapy in standard- and high-risk newly-diagnosed multiple myeloma: A pooled analysis of 2 phase III trials
Mattia D'Agostino, Lorenzo De Paoli, Concetta Conticello, et al.
Blood
|
December 4, 2023
Predictors of unsustained measurable residual disease negativity in patients with multiple myeloma
Mattia D'Agostino, Giuseppe Bertuglia, Delia Rota-Scalabrini, et al.
The New England Journal of Medicine
|
September 4, 2014
Autologous transplantation and maintenance therapy in multiple myeloma
Antonio Palumbo, Federica Cavallo, Francesca Gay, et al.
Transplantation and Cellular Therapy
|
June 9, 2021
The 2020 BMT CTN Myeloma Intergroup Workshop on Immune Profiling and Minimal Residual Disease Testing in Multiple Myeloma
Sarah A Holstein, Nizar Bahlis, P Leif Bergsagel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 31, 2022
Identification of High-Risk Multiple Myeloma With a Plasma Cell Leukemia-Like Transcriptomic Profile
Davine Hofste Op Bruinink, Rowan Kuiper, Mark van Duin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 19, 2015
Continuous Therapy Versus Fixed Duration of Therapy in Patients With Newly Diagnosed Multiple Myeloma
Antonio Palumbo, Francesca Gay, Federica Cavallo, et al.
Haematologica
|
February 6, 2014
European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma
Monika Engelhardt, Evangelos Terpos, Martina Kleber, et al.
Blood Cancer Journal
|
June 4, 2021
Minimal residual disease assessment by multiparameter flow cytometry in transplant-eligible myeloma in the EMN02/HOVON 95 MM trial
Stefania Oliva, Davine Hofste Op Bruinink, Lucie Rihova, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
May 13, 2025
Daratumumab for newly diagnosed multiple myeloma: Pooled analysis of patients aged ≥65 years from GRIFFIN and PERSEUS
Paula Rodriguez-Otero, Peter M Voorhees, Mario Boccadoro, et al.
Page
of 18
Search research articles
Search
Showing results (121-130 of 174) with videos related to
Sort By:
Page
of 18
Haematologica
|
August 10, 2012
Safety of thalidomide in newly diagnosed elderly myeloma patients: a meta-analysis of data from individual patients in six randomized trials
Antonio Palumbo, Anders Waage, Cyrille Hulin, et al.
Critical Reviews in Oncology/Hematology
|
November 19, 2018
Continuous therapy in standard- and high-risk newly-diagnosed multiple myeloma: A pooled analysis of 2 phase III trials
Mattia D'Agostino, Lorenzo De Paoli, Concetta Conticello, et al.
Blood
|
December 4, 2023
Predictors of unsustained measurable residual disease negativity in patients with multiple myeloma
Mattia D'Agostino, Giuseppe Bertuglia, Delia Rota-Scalabrini, et al.
The New England Journal of Medicine
|
September 4, 2014
Autologous transplantation and maintenance therapy in multiple myeloma
Antonio Palumbo, Federica Cavallo, Francesca Gay, et al.
Transplantation and Cellular Therapy
|
June 9, 2021
The 2020 BMT CTN Myeloma Intergroup Workshop on Immune Profiling and Minimal Residual Disease Testing in Multiple Myeloma
Sarah A Holstein, Nizar Bahlis, P Leif Bergsagel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 31, 2022
Identification of High-Risk Multiple Myeloma With a Plasma Cell Leukemia-Like Transcriptomic Profile
Davine Hofste Op Bruinink, Rowan Kuiper, Mark van Duin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 19, 2015
Continuous Therapy Versus Fixed Duration of Therapy in Patients With Newly Diagnosed Multiple Myeloma
Antonio Palumbo, Francesca Gay, Federica Cavallo, et al.
Haematologica
|
February 6, 2014
European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma
Monika Engelhardt, Evangelos Terpos, Martina Kleber, et al.
Blood Cancer Journal
|
June 4, 2021
Minimal residual disease assessment by multiparameter flow cytometry in transplant-eligible myeloma in the EMN02/HOVON 95 MM trial
Stefania Oliva, Davine Hofste Op Bruinink, Lucie Rihova, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
May 13, 2025
Daratumumab for newly diagnosed multiple myeloma: Pooled analysis of patients aged ≥65 years from GRIFFIN and PERSEUS
Paula Rodriguez-Otero, Peter M Voorhees, Mario Boccadoro, et al.
Page
of 18